Geriatrik Hastalarda Nöroonkolojik Sorunlar (Geriatrik Nöroonkoloji)

Dünya popülasyonu giderek yaşlanmakta ve bununla orantılı olarak bu yaşgrubunda görülen hastalıkların insidans ve prevalansı artmaktadır. Özelliklebu yaş grubunda görülen nöroonkolojik hastalıklar kanser metastazları veglioblastomdur. Eşlik eden başka hastalıkların olması, kullanılan ilaçların yanetkileri ve uygulananan tedavi yöntemlerine bağlı gelişebilen komplikasyonlar,bu grup hastalarda tedavi planlamasını zorlaştırmakta, morbidite/mortaliteoranlarının artmasına neden olmaktadır. Hastalarda yaşam kalitesini vefonksiyonel bütünlüğü bozmadan en uygun tedavinin seçilebilmesi için öncedenvar olan ve sonradan eklenebilecek sorunların multidisipliner olarakdeğerlendirilmesi önemlidir.

Neurooncological Problems in Geriatric Patients (Geriatric Neurooncology)

World human population is getting older and according to this, the incidence– prevalance of the diseases in this age group is increasing. Neurooncological diseases, especially seen in this age group are metastasis and glioblastoma. Comorbidities, therapy-related side effects and complications of the treatment modalities make the management difficult, and also increase the ratio of mobridity/ mortality. It is important to evaluate the problems in multidisciplinary process, to choose the best treatment modality without effecting the quality of life and functional independence

PDF

___

Pallis AG, Fortpied C, Wedding U, et al. EORTC elderly task force position paper: Approach to the older cancer patient. Eur J Cancer 2010;46 (9):1502- 1513
Decoster L, Van Puyvelde K, Mohile S, Wedding U, Basso U, Colloca G et al. Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations. Ann Oncol 2015;26(2):288-300
Cloney M, D’Amico R, Lebovic J, Nazarian M, Zacharia BE, Sisti MB, Bruce JN, McKhann GM, Iwamoto FM, Sonabend AM. Frailty in geriatric glioblastoma patients: a predictor of operative morbidity and outcome. World Neurosurgery 2016;89:362-367
Gehring K, Patwardhan SY, Collins R et al. A randomized trial on the efficacy of mthylphenidate and modafinil for improving cognitive functioning and symptoms in patients with primary brain tumor. J Neurooncol 2012;107:165-174
Perez-Larraya JG, Delattre JY. Treating glioblastoma in the elderly. CNS Oncol 2012;1:193-201
Minniti G, Lanzetta G, Scaringi C, Caporello P, Salvati M, Arcella A, et al. Phase II study of short- course radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma. Int J Radiat Oncol Biol Phys. 2012;83(1):93-9.
Wick W, Platten M, Meisner C, et al. Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncol. 2012;13(7):707- 715
Malmstrom A, Gronberg BH, Marosi C, et al. Temozolomide versus standart 6-week radiotherapy versus hypofractioned radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomized, phase 3 trial. Lancet Oncol. 2012;13 (9):916-926
Kono M, Arakawa Y, Mineharu Y, Ohka F, Kinoshita M, Nakae S, Miyashita K, Luchi T, Hirose Y, Natsume A. et al. P09.50 Phase I tial of temozolomide plus bevacizumab for newly diagnosed high-grade gliomas in the elderly: Interim report. Neuro-Oncology 2017;19(3):81
Holdhoff M, Chamberlain MC. Controversies in the treatment of elderly patients with newly diagnosed glioblastoma. J Natl Compr Canc Netw. 2013;11(9):1165- 1173
Perez-Larraya, Ducray F, Chinot O, Thomas IC, Taillandier L, Guillamo JS et al. Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial. Journal of Clınıcal Oncology 2011;29 (22):3050-3055
Roa W, Brasher PM, Bauman G, et al. Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol. 2004;22(9):1583-1588
Stupp R, Mason WP, van den Bert MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987-996
Crossen JR, Garwood D, Glatstein E, Neuwelt EA. Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. J Clin Oncol 1994;12:627-42
D’Amico RS, Cloney MB, Sonabend AM, Zacharia B, Nazarian MN, Iwamoto FM, Sisti MB, Bruce JN, McKhann GM. The safety of surgery in elderly p a - tients with primary and recurrent glioblastoma. World Neurosurgery 2015;84(4):913- 919
Chaichana KL, Garzon_Muvdi T, Parker S et al. Supratentorial glioblastoma multiforme: the role of surgical resection versus biopsy among older patients. Ann Surg Oncol 2011;18:239-245
Laigle-Donadey F, Sanson M. Pattern of care of high-grade gliomas. Rev Prat 2006;56:1779-1786
Johans SJ, Garst JR, Burkett DJ, Grahnke K, Martin B, Ibrahim TFm Anderson DE, Prabhu VC. Identification of preoperative and intraoperative risk factors for complications in the elderly undergoing elective craniotomy. World Neurosurgery 2017;107:216-225
Fujita T, Sakurai K. Multivariate analysis of risk factors for postoperative pneumonia. Am J Surg 1995;169:304-307.
Karkouri K, Wijeysundera DN, Yau TM, Beattie WS, Abdelnaem E, Mc Cluskey SA, et al. The independent association of massive blood loss with mortality in cardiac surgey. Transfusion 2004;44:1453- 1462.
Khaldi A, Helo N, Schneck MJ, Origitano TC. Venous thromboembolism: deep venous thrombosis and pulmonary embolism in a neurosurgical population. J neurosurg 2011;114:40-46
Oh T, Safaee M, Sun MZ, Garcia RM, Mc Dermott MW, Parsa AT, et al. Surgical risk factors for post-operative pneumonia following meningioma resection. Clin Neurol Neurosurg 2014;118:76-79.
Waterhouse E, Towne A. Seizures in the elderly: Nuances in presentation and treatment. Cleve Clin J Med 2005;72(suppl 3):S26-S37
Arif H, Buchsbaum R, Pierro J et al. Comparative effectiveness of 10 antiepileptic drugs in older adults witj epilepsy. Arch Neurol 2010;67:408-415
Drappatz J, Schiff D, Kesari S, et al. Medical management of brain tumor patients. Neurol Clin 2007;25:1035-1071
Hegi ME, Diserens A-C, Gorlia T, et al. MGMT Gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005;352(10):997- 1003 16. Perez-Larraya JG, Delattre JY. Management of elderly patients with gliomas. The Oncologist 2014;19:1258-1267
Bauchet L, Zouaoui S, Darlix A, Champfleur NM, Ferreira E, Fabbro M, Kerr C, Taillandier L. Assessment and treatment relevance in elderly glioblastoma patients. Neuro-Oncology 2014;16 (11):1459-1468
Ohgaki H, Kleihues P. The definition of primary and secondary glioblastoma. Clin Cancer Res. 2013;19(4):764-772
McDonald KL, McDonnell J, Muntoni A, et al. Presence of alternative lengthening of telomeres mechanism in patients with glioblastoma identifies a less aggressive tumor type with longer survival. J Neuropathol Exp Neurol. 2010;69(7):729-736
Batchelor TT, Betensky RA, Esposito JM, et al. Age-dependent prognostic effects of genetic alterations in glioblastoma. Clin Cancer Res. 2004;10(1 Pt 1):228-233
Chargari C, Feuvret L, Bauduceau O, et al. Treatment of elderly patients with glioblastoma: From clinical evidence to molecular highlights. Cancer Treat Rev. 2012;38(8):988-995
Pruitt AA. Medical management of patients with brain tumors. Curr Treat Options Neurol 2011;13:413-426.
Dolecek TA, Propp JM, Stroup NE, et al. CBTRUS statistical report: primary brain and central nervoussystem tumors diagnosed in the United States in 2005-2009. Neuro-Oncol. 2012;14 (5):v1-v49
Weller M, Platten M, Roth P, Wick W. Geriatric neuro-oncology: from mythology to biology. Neurology 2011;24:599-604
Loh D, Hogg F, Edwards P, MacColl J,Brogna C,- Bhangoo R. Two year experience of multi- disciplinary team (MDT) outcomes for brain metastases in a tertiary neuro-oncology centre. British J of Neurosurgery, 2017;https:// doi.org/10.1080/02688697.2017.1368449
Janelsins MC, Kohli S, Mohile SG, Usuki K, Ahles TA, Morrow GR. An update on cancer and chemotherapy related cognitive dysfunction:current status. Semin Oncol 2011;38(3):431-438
Delafuente JC. The silver tsunami is coming: Will pharmacy be swept away with the tide? Am J Pharm Educ 2009;73:1
Morioka T, Miyazaki H, Tsuruta K. Problems in neurosurgical operations on elderly patients-from the viewpoint of Anesthesiology. Neurol Med Chir (Tokyo) 1980;20:713-720
(http://www.tuik.gov.tr;08.07.2010) Saglik Bakanligi 2010 yili istatistikleri- Saglik Bakanligi Yayinlari, 2010;Ankara
Aboderin IA, Beard JR. Older people’s health in sub-Saharan Africa. Lancet. 2015; Feb 14;385 (9968):e9-11